The trial has reached 75% of the targeted enrollment, and topline results continue to be expected in the first half of 2025 NEW HAVEN, Conn., Dec. 12, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc.
Pilot studies and feasibility trials form a critical component of the clinical research process by enabling investigators to assess the practicality of study protocols on a smaller scale prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback